Cardiac Arrhythmias Associated with Bactrim DS
Mechanism of Arrhythmia Risk
- The sulfamethoxazole component of trimethoprim-sulfamethoxazole can cause QT interval prolongation and torsades de pointes (TdP) by blocking potassium channels in cardiac tissue 1
- Genetic polymorphisms can increase individual susceptibility - some patients have potassium channels that are several-fold more sensitive to block by sulfamethoxazole than normal, even though these genetic variants show normal function under normal conditions 1, 2
Risk Factors for Arrhythmias with Bactrim
- Patients with pre-existing heart disease, age over 80 years, female gender, concomitant use of other QT-prolonging medications, baseline prolonged QT interval, reduced drug elimination, bradycardia, electrolyte abnormalities, and genetic predisposition to QT prolongation are at increased risk of arrhythmias when taking Bactrim DS 3
- Combination with inhibitors of the renin-angiotensin system can lead to hyperkalemia and increased risk of sudden death 4
Clinical Recommendations
- The European Society of Cardiology recommends performing ECG screening before initiating Bactrim DS therapy to exclude prolonged QTc interval (>450 ms for men and >470 ms for women) 3
- Patients with prolonged QTc interval should not receive Bactrim DS, and follow-up ECG should be performed one month after initiating therapy to monitor for QTc prolongation 3
- The American Heart Association suggests obtaining a thorough medication history to identify other QT-prolonging agents that could interact with Bactrim DS, and discontinuing Bactrim DS if QTc prolongation develops during treatment 3
- Use of Bactrim DS should be with extreme caution in patients with known cardiac disease or history of arrhythmias 4
Management of Bactrim-Induced Arrhythmias
- The European Heart Rhythm Association recommends immediately discontinuing the drug if arrhythmias are suspected, maintaining normal serum potassium levels, and considering intravenous magnesium for management of TdP 4
- Temporary cardiac pacing may be necessary in severe cases, and isoproterenol can be used to increase heart rate and shorten ventricular action potential duration in cases of TdP 4